Newsroom |  Contact Us

Medical Advisory Board

Amir Kazory, MD

Amir Kazory, MD

Dr. Amir Kazory is Professor of Medicine and Vice-Chief of Clinical Affairs in the Division of Nephrology, Hypertension, and Renal Transplantation at the University of Florida. His main research interest is the nephrologic aspects of heart failure, disorders of water homeostasis, cardiorenal syndrome, and the interactions between kidney and heart in various pathologic settings.

Dr. Kazory has been involved in clinical research projects including those related to extracorporeal and pharmacologic therapies that are currently offered to patients with cardiorenal syndrome and other disorders of water homeostasis and congestive states. He regularly provides talks on these topics at various national and international conferences in US and overseas.

Steven G. Coca, DO

Steven G. Coca, DO

Dr. Steven G. Coca is a graduate of the University of New England College of Osteopathic Medicine. He completed his medical residency and clinical nephrology fellowship at Yale University and Yale New Haven Hospital in Connecticut. He also received a Master’s Degree in Epidemiology and Public Health during his training at Yale, later serving as an Assistant Professor in the Section of Nephrology until his recruitment to Mount Sinai in 2014 as Associate Professor. Currently, Dr. Coca is the Director for Clinical Research for the Division of Nephrology and is the Associate Chair for Clinical and Translational Research for the Department of Medicine at the Icahn School of Medicine at Mount Sinai.

Dr. Coca’s research has focused on using novel biomarkers to improve risk stratification in patients with acute kidney injury and patients at risk or with prevalent chronic kidney disease. He has been continually funded by the NIH over the last decade for multiple biomarker-related projects. He is the co-founder of RenalytixAI.

William E. Cohn, MD

William E. Cohn, MD

Dr. William E. “Billy” Cohn is a Vice President for Johnson & Johnson’s Medical Devices Companies and the Executive Director of the Center for Device Innovation at the Texas Medical Center in Houston. In addition, he is a tenured Professor of Surgery in the Department of Cardiac Transplantation and Mechanical Circulatory Assist at Baylor College of Medicine and an Adjunct Professor of Bioengineering at both Rice University and the University of Houston.

Prior to joining Johnson & Johnson, Dr. Cohn was a cardiothoracic surgeon and the Director of the legendary Cullen Cardiovascular Research Laboratory at the Texas Heart Institute in Houston where he was, and continues to be, intimately involved in the development of the continuous-flow, totally implantable, artificial heart. In 2011, Dr. Cohn and Dr. O. H. Frazier successfully implanted the first pulseless total heart replacement device in a human patient.

Dr. Cohn sits on the Board of Directors of BiVACOR USA and Cardiovascular Systems Inc. Previously, he sat on the boards of SentreHeart, Inc., TVA Medical, Tenaxis Medical Inc., Pluromed Inc., and On-X Life Technologies.

Brian Jaski, MD

Brian Jaski, MD

Dr. Brian Jaski earned undergraduate degrees in electrical engineering and biology at MIT. He graduated from Harvard Medical School where he subsequently went on to do his cardiology fellowship at the Brigham and Women’s Hospital.

Since 1985, Dr. Jaski has been the medical director of the Advanced Heart Failure and Cardiac Transplant program at Sharp Memorial Hospital associated with the San Diego Cardiac Center.

Dr. Jaski has published in the areas of therapies for decompensated heart failure, circulatory support devices, and cardiac transplant. He is board certified in the subspecialty of Advanced Heart Failure and Cardiac Transplant.

Daniel Beckles, MD

Daniel Beckles, MD

Dr. Daniel Beckles is a senior cardiothoracic surgeon at Baylor Scott & White Health in Central Texas. He obtained his MD degree from SUNY Downstate Medical School in Brooklyn NYC and stayed there for his PhD in Cardiovascular Molecular and Cell Biology and General Surgery residency. His Cardiothoracic Surgery residency was at UT Southwestern Medical Center in Dallas. He spent an additional year at the Brigham & Women’s Hospital-Instructor of Surgery at Harvard Medical School before his first attending position at Mount Sinai Medical Center in NYC. He spent 5 years at UT Medical Branch in Galveston Texas and was then Chief of Cardiothoracic Surgery at Downstate Medical Center in Brooklyn, NYC.

Dr. Beckles has published in text books, peer reviewed journals, and has 2 US patents on heart diseases. His focus is on clinical excellence, education, and research. His expertise is in the management of end stage heart disease, multiorgan failure and surgical leadership. He is double boarded by the American Board of Surgery and the American Board of Thoracic Surgery.

Dr. Beckles is the Chief Medical Officer (CMO) of Trinbago Progressive Association, President elect of the SUNY Downstate Alumni Board of Managers, Advisor for Noigel, and consultant for CHF Solutions and Edwards Lifesciences.

John L. Jefferies, MD, MPH

John L. Jefferies, MD, MPH

Dr. John Lynn Jefferies is the Jay M. Sullivan Endowed Chair in Cardiovascular Medicine and Chief of Cardiology at the University of Tennessee Health Science Center (UTHSC). He also serves as Co-Director of the Methodist University of Tennessee Cardiovascular Institute and the Methodist Cardiovascular Service Line. Dr. Jefferies is also a Professor of Pediatric Cardiology and a Research Member of St. Jude Children’s Research Hospital.

Dr. Jefferies graduated from the University of Tennessee College of Medicine and did his Residency and Fellowships at the University of Kentucky in Lexington and Baylor College of Medicine in Houston, TX. Prior to joining UT Methodist, he was a Professor at the University of Cincinnati and Cincinnati Children’s Hospital.

Dr. Jefferies has published nearly 250 articles and abstracts on a variety of topics and has authored chapters in over 15 text books.

Aroti Hegde, MD

Aroti Hegde, MD

Dr. Aroti Hegde is a nephrologist at MedStar Health. She is certified by the American Board of Internal Medicine, with a subspecialty in Nephrology and by the American Society of Hypertension, as a specialist in clinical hypertension. Dr. Hegde is a member of the American Medical Association, American College of Physicians, American Society of Nephrology, International Society of Nephrology and the American Society of Hypertension.

Dr. Hegde received her medical degree from Bangalore University in Bangalore, India. She completed her residency at MedStar Washington Hospital Center, where she also served as chief resident in Internal Medicine. Dr. Hegde completed a fellowship in Nephrology at Duke University Medical Center. Among her many achievements, she received the Joe H. Gaskin Excellence In Teaching Award from both the Hospital Center and MedStar Georgetown University Hospital.

Sitaramesh Emani, MD

Sitaramesh Emani, MD

Dr. Sitaramesh Emani is an Associate Professor of Medicine at the Ohio State University with dual training in both Advanced Heart Failure/Cardiac Transplant as well as Interventional Cardiology. He also serves as the Director of Heart Failure Clinical Research.

Dr. Emani interests include device-based therapies for heart failure patients, including mechanical circulatory support, remote monitoring technologies, other implantable technologies, and devices to treat acute heart failure.

Most recently, Dr. Emani is spearheading the Cardiogenic Shock team at OSU.

Mehdi Oloomi, MD

Mehdi Oloomi, MD

Dr. Mehdi Oloomi has been a Cardiothoracic Intensivist for the last eighteen years. He has been the Medical Director of Cardiothoracic ICU in Maimonides Medical Center, St. Michael’s Medical Center, and most recently at Mount Sinai Medical Center- Main Campus for the past nine years.

Dr. Oloomi is very involved in the concept of cardiac team and closed ICU related to post-op management. His training in Internal Medicine, Pulmonary, and Critical Care Medicine along with his extensive experience provides a unique perspective in the care of cardiothoracic surgery patients.

Dr. Oloomi’s areas of interest include Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Hemostasis/ Coagulopathy. He has been extensively involved in the development of protocols for Renal Replacement Therapy (RRT).

Maria Rosa Costanzo, MD

Maria Rosa Costanzo, MD

Dr. Costanzo is the medical director, Heart Failure Research, at Advocate Heart Institute, and the medical director for Advanced Heart Failure at Edward Hospital Center in Illinois. She currently serves on the board of directors for the Heart Failure Society of America. In addition, she is a member of several medical societies and a fellow with the American College of Cardiology, American College of Physicians, American Heart Association, and the European Society of Cardiology, and a Gold Member of the Heart Failure Association of the European Society of Cardiology. Dr. Costanzo has over 250 publications in peer reviewed journals, book chapters and manuscripts. She received her medical degree with honors from Facolta’ Di Medicina e Chirurgia dell’ Universita’ di Bologna, Bologna, Italy.

CHF Solutions